Lilly says lupus drug dropped from pipeline failed to show efficacy

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

PE Firm Invests in Pyx Health

What You Should Know: Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness

July 20, 2023

MoonLake’s stock falls more than 20% despite mid-stage success in psoriatic arthritis

MoonLake Immunotherapeutics’ nanobody candidate triumphed in a mid-stage psoriatic arthritis trial following past successes in hidradenitis suppurativa and psoriasis, but its shares plunged amid higher-than-expected

November 7, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of October 16

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of October 16. Aside from presenting a synopsis of events, we provide

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.